Koninklijke Philips Shares Outstanding 2010-2024 | PHG

Koninklijke Philips shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Koninklijke Philips shares outstanding for the quarter ending September 30, 2024 were 0.944B, a 6.8% increase year-over-year.
  • Koninklijke Philips 2024 shares outstanding were 0.933B, a 1.74% increase from 2023.
  • Koninklijke Philips 2023 shares outstanding were 0.917B, a 4.06% increase from 2022.
  • Koninklijke Philips 2022 shares outstanding were 0.882B, a 3.08% decline from 2021.
Koninklijke Philips Annual Shares Outstanding
(Millions of Shares)
2024 933
2023 917
2022 882
2021 910
2020 917
2019 913
2018 936
2017 945
2016 929
2015 924
2014 923
2013 922
2012 927
2011 956
2010 948
2009 929
Koninklijke Philips Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 944
2024-06-30 942
2023-06-30 947
2023-03-31 882
2022-06-30 884
2021-06-30 913
2020-06-30 914
2019-06-30 914
2018-06-30 929
2017-06-30 940
2016-12-31 929
2016-09-30 931
2016-06-30 918
2016-03-31 925
2015-12-31 924
2015-09-30 928
2015-06-30 915
2015-03-31 918
2014-12-31 923
2014-09-30 928
2014-06-30 917
2014-03-31 926
2013-12-31 922
2013-09-30 922
2013-06-30 916
2013-03-31 920
2012-12-31 927
2012-09-30 936
2012-06-30 927
2012-03-31 927
2011-12-31 939
2011-09-30 962
2011-06-30 970
2011-03-31 958
2010-12-31 953
2010-09-30 954
2010-06-30 949
2010-03-31 936
2009-12-31 933
2009-09-30 926
2009-06-30 902
2009-03-31 926
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.536B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.641B 27.61
Boston Scientific (BSX) United States $152.191B 38.10
Stryker (SYK) United States $148.126B 30.97
EssilorLuxottica (ESLOY) France $127.448B 0.00
Medtronic (MDT) Ireland $110.055B 16.07
Lonza Group Ag (LZAGY) Switzerland $49.786B 0.00
Haleon (HLN) United Kingdom $48.281B 27.46
ResMed (RMD) United States $36.314B 27.27
GE HealthCare Technologies (GEHC) United States $33.934B 16.11
Agilent Technologies (A) United States $32.944B 21.76
Terumo (TRUMY) Japan $28.086B 0.00
Insulet (PODD) United States $22.286B 87.48
Zimmer Biomet Holdings (ZBH) United States $19.433B 12.48
Baxter (BAX) United States $16.360B 12.22
Smith & Nephew SNATS (SNN) United Kingdom $12.456B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $7.190B 24.31
Lantheus Holdings (LNTH) United States $5.502B 13.88
Prestige Consumer Healthcare (PBH) United States $4.350B 19.43
Perrigo (PRGO) Ireland $3.711B 9.40
ICU Medical (ICUI) United States $3.552B 26.20
Haemonetics (HAE) United States $3.528B 15.37
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.144B 26.13
QuidelOrtho (QDEL) United States $2.531B 17.41
GN Store Nord (GNNDY) Denmark $2.188B 18.12
LeMaitre Vascular (LMAT) United States $1.863B 41.65
AtriCure (ATRC) United States $1.575B 0.00
Neogen (NEOG) United States $1.411B 18.06
AdaptHealth (AHCO) United States $1.229B 12.48
Kestra Medical Technologies (KMTS) United States $1.211B 0.00
Green Thumb Industries (GTBIF) United States $1.152B 25.91
BioLife Solutions (BLFS) United States $1.135B 0.00
InMode (INMD) Israel $1.043B 9.55
Phibro Animal Health (PAHC) United States $0.992B 12.69
Evolus (EOLS) United States $0.643B 0.00
CeriBell (CBLL) United States $0.620B 0.00
Owens & Minor (OMI) United States $0.552B 4.58
Curaleaf Holdings (CURLF) Canada $0.545B 0.00
Valneva SE (VALN) France $0.539B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.539B 0.00
Tilray Brands (TLRY) Canada $0.462B 0.00
Surmodics (SRDX) United States $0.387B 0.00
Cresco Labs (CRLBF) United States $0.357B 0.00
SNDL (SNDL) Canada $0.347B 0.00
Capricor Therapeutics (CAPR) United States $0.325B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
VAREX IMAGING (VREX) United States $0.310B 11.39
Sanara MedTech (SMTI) United States $0.305B 0.00
Aurora Cannabis (ACB) Canada $0.284B 50.60
Canopy Growth (CGC) Canada $0.268B 0.00
Sanuwave Health (SNWV) United States $0.261B 0.00
Cerus (CERS) United States $0.258B 0.00
Viemed Healthcare (VMD) United States $0.257B 21.70
ZimVie (ZIMV) United States $0.248B 11.28
Verano Holdings (VRNOF) United States $0.248B 0.00
Quanterix (QTRX) United States $0.222B 0.00
Omeros (OMER) United States $0.221B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.200B 0.00
High Tide (HITI) Canada $0.192B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.29
Organigram Global (OGI) Canada $0.171B 0.00
Brainsway (BWAY) Israel $0.167B 51.94
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.145B 17.82
Jin Medical (ZJYL) China $0.141B 0.00
Exagen (XGN) United States $0.123B 0.00
TerrAscend (TSNDF) Canada $0.107B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Agape ATP (ATPC) $0.083B 0.00
Fonar (FONR) United States $0.077B 10.76
Veru (VERU) United States $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Zynex (ZYXI) United States $0.065B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Apyx Medical (APYX) United States $0.042B 0.00
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 13.10
Safety Shot (SHOT) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
Nephros (NEPH) United States $0.022B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00